Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations

BMC Clinical Pharmacology

Volumn 1, Issue , 2001, Pages

  de Abajo, Francisco J ^a   García Rodríguez, Luis A ^b  

^a Agencia Espanola del Medicamento   (Spain)

^b Department of Pharmacoepidemiology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTICOAGULANT AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; STEROID;

ADULT; AGED; ANALGESIA; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; DATA BASE; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG EXPOSURE; DRUG MEGADOSE; DRUG POTENTIATION; DRUG USE; DUODENUM BLEEDING; DUODENUM PERFORATION; DYSPEPSIA; ENTERIC COATED TABLET; FEMALE; GENERAL PRACTICE; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; RANDOMIZATION; RISK ASSESSMENT; RISK REDUCTION; STOMACH HEMORRHAGE; STOMACH PERFORATION; UPPER GASTROINTESTINAL BLEEDING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; CHEMISTRY, PHARMACEUTICAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0001834897     PISSN: 14726904     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-1-1     Document Type: Article

References (22)

1. Patrono C: Aspirin as an antiplatelet drug. N Engl J Med 1994, 330:1287-1294
2. Henry D, Lim LLY, García Rodríguez LA, Pérez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT: Variability in risk of gastrointestinal complications with individual NSAIDs. results of a collaborative meta-analysis. Br Med J 1996, 312:1563-1566
3. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M, Wainwright P: Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995, 310:827-830
4. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S: Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996, 348:1413-1416
5. Rowland M, Tozer TN: Clinical pharmacokinetics- concepts and applications. Lea & Febiger, Philadelphia: 1980,
6. Graham DY, Smith JL: Aspirin and the stomach. Ann Intern Med 1986, 104:390-398
7. Hoftiezer JW, Silvoso GR, Burks M, Ivey KJ: Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980, 2:609-612
8. Lanza FL, Royer GL Jr, Nelson RS: Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980, 303:136-138
9. Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ: Aspirin-induced gastric mucosa damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol 1991, 32:77-83
10. García Rodríguez LA, Hernández S: The risk of upper gastrointestinal complications among users of paracetamol and other non-steroidal antiinflammatory drugs. Epidemiology
11. García Rodríguez LA, Pérez Gutthann S: Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998, 45:419-425
12. Jick H, Jick SS, Derby LE: Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991, 302:766-768
13. García Rodríguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet. 1994, 343:769-772
14. Walker AM: Case-control studies: sampling the source population. In: Walker AM. Observation and Inference: An introduction to the methods of epidemiology. Chestnut Hill, MA: Epidemiology Resources Inc., 1991, 75-80
15. Pérez Gutthann S, García Rodríguez LA, Raiford DS: Individual nonsteroidal anti-inflammatory drugs and hospitalizations for upper gastrointestinal bleeding and perforation. Epidemiology. 1997, 8:18-24
16. De Abajo FJ, García Rodríguez LA, Montero D: Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: a population based case-control study. Br Med J 1999, 319:1106-1109
17. Rothman KJ: Modern Epidemiology, 1st ed, Little, Brown and Company, Boston: 1986,
18. Hosmer DW, Lemeshow S: Confidence interval estimation of interaction. Epidemiology 1992, 3:452-456
19. Ali M, McDonald JW, Thiessen JJ, Coates PE: Plasma acetylsalicylate and salicylate and platelet cyclo-oxygenase activity following plain and enteric-coated aspirin. Stroke 1980, 11:9-13
20. Wolfe MM, Lichtenstein DR, Singh G: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999, 340:1888-1899
21. Lanza FL: A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs. Scand J Gastroenterol Suppl 1989, 163:24-31
22. Yood MU, Rothman KJ, Johnson CC, Jick S, Lang J, Wells KE, Jick H: Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiology and Drug Safety 2000, 9 (suppl 1):S37